Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: A pilot study

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 10, 2010, Pages 1228-1234

  Thalheimer, Ulrich ^a,b   De Iorio, Fosca ^a   Capra, Franco ^a   Lleo, Maria Del Mar ^a   Zuliani, Valeria ^a   Ghidini, Valentina ^a   Tafi, Maria Carla ^a   Caburlotto, Greta ^a   Gennari, Micol ^a   Burroughs, Andrew K ^b   Vantini, Italo ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

bacterial translocation; cirrhosis; intestinal dysfunction

Indexed keywords

BACTERIAL DNA; LACTULOSE; MANNITOL;

ADULT; AGED; ARTICLE; ASCITES; BACTERIAL OVERGROWTH; BACTERIAL TRANSLOCATION; BLOOD SAMPLING; CLINICAL ARTICLE; ENTEROBACTERIACEAE; FEMALE; HUMAN; INTESTINE FUNCTION; INTESTINE MOTILITY; LIVER CIRRHOSIS; MALE; NONHUMAN; PRIORITY JOURNAL;

ADULT; AGED; ASCITES; ASCITIC FLUID; BACTERIAL INFECTIONS; BACTERIAL TRANSLOCATION; DISEASE PROGRESSION; DNA, BACTERIAL; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL ABSORPTION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PILOT PROJECTS;

EID: 77957598296     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32833b4b03     Document Type: Article

References (41)

1. Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 2001;33:41-48.
2. Thalheimer U, Triantos CK, Samonakis DN, Patch D, Burroughs AK. Infection, coagulation, and variceal bleeding in cirrhosis. Gut 2005;54:556-563.
3. Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1998;27:1207-1212.
4. Montalto P, Vlachogiannakos J, Cox DJ, Pastacaldi S, Patch D, Burroughs AK. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol 2002;37:463-470.
5. Ruiz-del-Arbol L, Urman J, Fernandez J, Gonzalez M, Navasa M, Monescillo A, et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003;38:1210-1218.
6. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-409.
7. Wiest R, Rath HC. Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol 2003;17:397-425.
8. Guarner C, Gonzalez-Navajas JM, Sanchez E, Soriando G, Frances R, Chiva M, et al. The detection of bacterial DNA in blood of rats with CCl4-induced cirrhosis with ascites represents episodes of bacterial translocation. Hepatology 2006;44:633-639.
9. Frances R, Benlloch S, Zapater P, Gonzalez JM, Lozano B, Munoz C, et al. A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites. Hepatology 2004;39:484-491.
10. Campillo B, Pernet P, Bories PN, Richardet JP, Devanlay M, Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol 1999;11:755-759.
11. Parlesak A, Schafer C, Schutz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 2000;32:742-747.
12. Madrid AM, Cumsille F, Defilippi C. Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease. Dig Dis Sci 1997;42:738-742.
13. Casafont F, Almohalla C, Garcia P, Pons R. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 1996;41:552-556.
14. Chang CS, Chen GH, Lien HC, Yeh HZ. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 1998;28:1187-1190.
15. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273:117-123.
16. Nikkari S, Lopez FA, Lepp PW, Cieslak PR, Ladd-Wilson S, Passaro D, et al. Broad-range bacterial detection and the analysis of unexplained death and critical illness. Emerg Infect Dis 2002;8:188-194.
17. Lleo MM, Bonato B, Tafi MC, Signoretto C, Pruzzo C, Canepari P. Molecular versus culture methods for the detection of bacterial faecal indicators in groundwater for human use. Lett Appl Microbiol 2005;40:289-294.
18. Dastych M, Dastych M Jr, Novotna H, Cihalova J. Lactulose/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn's disease. Dig Dis Sci 2008;53:2789-2792.
19. Goulis J, Patch D, Burroughs AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet 1999;353:139-142.
20. Chesta J, Defilippi C, Defilippi C. Abnormalities in proximal small bowel motility in patients with cirrhosis. Hepatology 1993;17:828-832.
21. Madrid AM, Brahm J, Antezana C, Gonzalez-Koch A, Defilippi C, Pimentel C, et al. Small bowel motility in primary biliary cirrhosis. Am J Gastroenterol 1998;93:2436-2440.
22. Madrid AM, Brahm J, Buckel E, Silva G, Defilippi C. Orthotopic liver transplantation improves small bowel motility disorders in cirrhotic patients. Am J Gastroenterol 1997;92:1044-1045.
23. Perez-Paramo M, Munoz J, Albillos A, Freile I, Portero F, Santos M, et al. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 2000;31:43-48.
24. Fiandra R, Esposito P, deMagistris L, Belletta M, Generoso M, Cartenè M, et al. Intestinal Permeability and liver cirrhosis. Dig Liver Dis 2004;36(Suppl 2):S247.
25. Keshavarzian A, Holmes EW, Patel M, Iber F, Fields JZ, Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol 1999;94:200-207.
26. Ramachandran A, Balasubramanian KA. Intestinal dysfunction in liver cirrhosis: Its role in spontaneous bacterial peritonitis. J Gastroenterol Hepatol 2001;16:607-612.
27. Crossley IR, Williams R. Spontaneous bacterial peritonitis. Gut 1985;26:325-331.
28. Cirera I, Bauer TM, Navasa M, Vila J, Grande L, Taura P, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001;34:32-37.
29. Garcia-Tsao G, Lee FY, Barden GE, Cartun R, West AB. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 1995;108:1835-1841.
30. El-Naggar MM, Khalil E, El-Daker MA, Salama MF. Bacterial DNA and its consequences in patients with cirrhosis and culture-negative, non-neutrocytic ascites. J Med Microbiol 2008;57(Pt 12):1533-1538.
31. Zapater P, Frances R, Gonzalez-Navajas JM, de la Hoz MA, Moreu R, Pascual S, et al. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis. Hepatology 2008;48:1924-1931.
32. Corazza GR, Menozzi MG, Strocchi A, Rasciti L, Vaira D, Lecchini R, et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990;98:302-309.
33. Aldersley MA, Howdle PD. Intestinal permeability and liver disease. Eur J Gastroenterol Hepatol 1999;11:401-403.
34. Madrid AM, Hurtado C, Venegas M, Cumsille F, Defilippi C. Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. Am J Gastroenterol 2001;96:1251-1255.
35. Chelarescu O, Chelarescu D, Tircoveanu E, Stratan I. Propranolol administration on post surgical infections in cirrhotic patients. J Hepatol 2003;38(Suppl 2):A173.
36. Hoshino S, Shinoura S, Akamine H, Kikuchi K, Keida Y. Effect of propranolol for the prevention of spontaneous bacterial peritonitis. Am J Gastroenterol 2000;95: A349.
37. Senzolo M, Cholongitas E, Marelli L, Thalheimer U, Patch D, Burroughs AK. The low incidence of bacterial infections could be a protective factor against variceal bleeding per se in hemodynamic responders to propranolol. Am J Gastroenterol 2006;101:2436-2437.
38. Rimola A, Bory F, Teres J, Perez-Ayuso RM, Arroyo V, Rodes J. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 1985;5:463-467.
39. Soriano G, Guarner C, Tomas A, Villanueva C, Torras X, Gonzalez D, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992;103:1267-1272.
40. Sandhu BS, Gupta R, Sharma J, Singh J, Murthy NS, Sarin SK. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites. J Gastroenterol Hepatol 2005;20:599-605.
41. Soares-Weiser K, Brezis M, Tur-Kaspa R, Paul M, Yahav J, Leibovici L. Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials. Scand J Gastroenterol 2003;38:193-200.